Advisors Preferred LLC acquired a new position in Genpact Limited (NYSE:G - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 79,897 shares of the business services provider's stock, valued at approximately $3,435,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in G. Jensen Investment Management Inc. boosted its stake in Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider's stock worth $7,449,000 after acquiring an additional 11,410 shares in the last quarter. Stifel Financial Corp bought a new position in shares of Genpact during the 3rd quarter worth about $1,197,000. Blue Trust Inc. grew its stake in shares of Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after buying an additional 441 shares during the period. Burney Co. grew its stake in shares of Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock valued at $5,618,000 after buying an additional 92,641 shares during the period. Finally, KBC Group NV bought a new stake in Genpact in the 4th quarter valued at about $298,000. 96.03% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, CEO Balkrishan Kalra sold 9,000 shares of the firm's stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,058 shares of company stock valued at $1,558,675 in the last ninety days. 2.80% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Several research analysts have issued reports on G shares. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and increased their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Robert W. Baird increased their target price on Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a report on Friday, November 8th. Needham & Company LLC boosted their price target on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $45.00 to $60.00 in a research note on Friday. Finally, Mizuho boosted their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, Genpact has an average rating of "Hold" and an average price target of $48.44.
Get Our Latest Analysis on G
Genpact Stock Up 0.6 %
Shares of G traded up $0.34 during trading hours on Tuesday, reaching $54.78. 2,119,869 shares of the stock traded hands, compared to its average volume of 1,527,999. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock has a fifty day simple moving average of $45.25 and a 200 day simple moving average of $41.55. The company has a market cap of $9.66 billion, a price-to-earnings ratio of 19.29, a PEG ratio of 1.63 and a beta of 1.20.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.61% and a net margin of 10.77%. On average, equities analysts forecast that Genpact Limited will post 3.08 EPS for the current year.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date is Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is 21.48%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
![Institutional Ownership by Quarter for Genpact (NYSE:G)](https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&Symbol=G)
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report